Editas Medicine (NasdaqGS:EDIT) Conference Transcript

Editas Medicine (NasdaqGS:EDIT) Conference October 14, 2025 07:00 AM ET Speaker0Hello, everyone. My name is Mitchell Kapoor. I'm a senior biotech analyst at H. C. Wainwright.It's my pleasure to welcome you to the genetic medicines conference. Today, I have Editas with me. I have this I have the pleasure of welcoming Gilmore O'Neill, the CEO, and Amy Bresen, the CFO. Thank you both for joining us today.Speaker1It's great to be with you, Mitch. Thanks for the time.Speaker2Thanks, Ryan. JustSpeaker0to kick us ...